Surgery Robots? Google? Yep.

Google and Johnson & Johnson are teaming up to develop robots that can perform surgery.

The companies say they are developing a “platform” to make robotic assistants to help doctors during surgery. Financial terms were not disclosed.

Here’s the full announcement from Johnson & Johnson:

Johnson & Johnson today announced that Ethicon, a medical device company in the Johnson & Johnson family of companies, has executed a definitive agreement to enter into a strategic collaboration with Google, Inc., working with the Life Sciences team on advancing surgical robotics to benefit surgeons, patients and health care systems.

The companies will bring together capabilities, intellectual property and expertise to create an innovative robotic-assisted surgical platform capable of integrating advanced technologies with the goal of improving health care delivery in the operating room. The collaboration was facilitated by Johnson & Johnson Innovation in California.

Robotic-assisted surgery is a type of minimally invasive surgery that uses technology to give surgeons greater control, access and accuracy during the surgical procedure while Benefitting patients by minimizing trauma and scarring, enabling accelerated post-surgical healing. The companies seek to develop new robotic tools and capabilities for surgeons and operating room professionals that integrate best-in-class medical device technology with leading-edge robotic systems, imaging and data analytics.

“For more than 60 years, Ethicon has developed products and technologies that have transformed the way surgery is done,” said Gary Pruden, Worldwide Chairman, Global Surgery Group, Johnson & Johnson. “This collaboration with Google is another important step in our commitment to advancing surgical care, and together, we aim to put the best science, technology and surgical know-how in the hands of medical teams around the world.”

The closing of the transaction is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions. The transaction is expected to close during the second quarter of 2015. Financial terms were not disclosed.